All posts tagged
Doudna and Charpentier Get Second CRISPR Patent in Europe
CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018
Europe Turns the Tables in the CRISPR Patent Battle
The Patent Office has Spoken: What does it Mean for CRISPR in Europe?
10 European Scientists who are the Best at Co-founding Biotech Companies
UPDATE: No Clear Winner in the CRISPR Patent Battle
CRISPR Thx’ Founder: “We have over $250M in the bank”
Bayer claims CRISPR Patents for Gene-Editing Agreements
Sorry CRISPR, you’ll have to wait another year to win a Nobel Prize!
CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9?
What happened this week? Woodford spent €800m, CRISPR discoverer moves to Berlin, the first Bacteria-made ink…
Emmanuelle Charpentier, co-discoverer of CRISPR-Cas9 Technology, comes to Berlin!
Labiotech UG, All Rights Reserved -
This website uses
to give you the best experience. Agree by clicking the 'Accept' button.